These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3838361)

  • 1. Charge transfer between fluorescein and tryptophan as a possible interaction in the binding of fluorescein to anti-fluorescein antibody.
    Gudgin Templeton EF; Ware WR
    Mol Immunol; 1985 Jan; 22(1):45-55. PubMed ID: 3838361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative binding properties of fluorescein and 9-hydroxyphenylfluoron (HPF) with murine monoclonal anti-fluorescein antibodies.
    Bedzyk WD; Swindlehurst CA; Voss EW
    Biochim Biophys Acta; 1992 Feb; 1119(1):27-34. PubMed ID: 1540631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of quenching of fluorescein by anti-fluorescein IgG antibodies.
    Watt RM; Voss EW
    Immunochemistry; 1977 Jul; 14(7):533-51. PubMed ID: 303233
    [No Abstract]   [Full Text] [Related]  

  • 4. Pressure-induced dissociation of fluorescein from the anti-fluorescein single-chain antibody 4-4-20.
    Coelho-Sampaio T; Voss EW
    Biochemistry; 1993 Oct; 32(41):10929-35. PubMed ID: 8218158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site contributions to fluorescein binding determined by in vitro heavy and light chain reassociations.
    Bedzyk WD; Voss EW
    Mol Immunol; 1991; 28(1-2):27-34. PubMed ID: 2011128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-metatype antibodies stabilize the fluorescein single-chain antibody 4-4-20 complex against dissociation by hydrostatic pressure.
    Coelho-Sampaio T; Voss EW
    J Biol Chem; 1994 Mar; 269(11):8146-52. PubMed ID: 8132540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal anti-fluorescein antibodies from autoimmune New Zealand mice.
    Ballard DW; Bates RM; Voss EW
    J Immunol; 1985 Jul; 135(1):433-9. PubMed ID: 3889156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-chain site-specific mutations of fluorescein-amino acid contact residues in high affinity monoclonal antibody 4-4-20.
    Denzin LK; Whitlow M; Voss EW
    J Biol Chem; 1991 Jul; 266(21):14095-103. PubMed ID: 1856233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solvent perturbation of the fluorescence of fluorescyl ligand bound to specific antibody. Fluorescence enhancement of antibody bound fluorescein (hapten) in deuterium oxide.
    Voss EW; Watt RM; Weber G
    Mol Immunol; 1980 Apr; 17(4):505-17. PubMed ID: 7393237
    [No Abstract]   [Full Text] [Related]  

  • 10. Solvent perturbation of the fluorescence of fluorescein bound to specific antibody. Fluorescence quenching of the bound fluorophore by iodide.
    Watt RM; Voss EW
    J Biol Chem; 1979 Mar; 254(5):1684-90. PubMed ID: 570194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of electrostatic interactions in the binding of fluorescein by anti-fluorescein antibody 4-4-20.
    Omelyanenko VG; Jiskoot W; Herron JN
    Biochemistry; 1993 Oct; 32(39):10423-9. PubMed ID: 8399186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives.
    Tetin SYu ; Mantulin WW; Denzin LK; Weidner KM; Voss EW
    Biochemistry; 1992 Dec; 31(48):12029-34. PubMed ID: 1457402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of secondary forces on the primary antibody-ligand interaction.
    Mummert ME; Voss EW
    Mol Immunol; 1995 Nov; 32(16):1225-33. PubMed ID: 8559147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural properties of an anti-fluorescein monoclonal IgM cryoglobulin.
    Dombrink-Kurtzman MA; Lacy MJ; Voss EW
    Mol Immunol; 1989 Aug; 26(8):779-87. PubMed ID: 2811871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatially resolved detection of antibody-antigen reaction on solid/liquid interface using total internal reflection excited antigen fluorescence and charge-coupled device detection.
    Hlady V; Lin JN; Andrade JD
    Biosens Bioelectron; 1990; 5(4):291-301. PubMed ID: 2119624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-4-20 anti-fluorescyl IgG Fab' recognition of membrane bound hapten: direct evidence for the role of protein and interfacial structure.
    Leckband DE; Kuhl T; Wang HK; Herron J; Müller W; Ringsdorf H
    Biochemistry; 1995 Sep; 34(36):11467-78. PubMed ID: 7547875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of antibodies with liposomes bearing fluorescent haptens.
    Petrossian A; Owicki JC
    Biochim Biophys Acta; 1984 Oct; 776(2):217-27. PubMed ID: 6477908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13-DE1.
    Böttger V; Peters L; Micheel B
    J Mol Recognit; 1999; 12(3):191-7. PubMed ID: 10398409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of ligand binding by monoclonal anti-fluorescyl antibodies.
    Kranz DM; Herron JN; Voss EW
    J Biol Chem; 1982 Jun; 257(12):6987-95. PubMed ID: 6806261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity.
    Jolley ME; Wang CH; Ekenberg SJ; Zuelke MS; Kelso DM
    J Immunol Methods; 1984 Feb; 67(1):21-35. PubMed ID: 6366066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.